A vaccine developed by Pfizer-BioNTech cut symptomatic COVID-19 disease by 85% after the first dose, according to Israeli researchers.
Pfizer COVID-19 vaccine 85% effective after single dose, Israeli researchers find
A vaccine developed by Pfizer-BioNTech cut symptomatic COVID-19 disease by 85% after the first dose, according to Israeli researchers.